目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 INSIGHTS FROM PRIMARY
2.2.2 SEGMENT ASSESMENT METHOLOGY
2.3 GROWTH FORECAST
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TRENDS/DISTRUPTIONS IMPACTING CUSTOMERS BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
5.5 SUPPLY/VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.8 PATENT ANALYSIS
5.9 KEY CONFERENCES & EVENTS 2023-2024
5.10 TRADE DATA
5.11 TARIFF AND REGULATORY LANDSCAPE
5.11.1 REGULATORY BODIES, GOVERNMENT AGENICES AND OTHER ORGANIZATIONS
5.12 PORTER’S FIVE FORCES’ ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTE
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITION RIVALRY
5.13 KEY STAKEHOLDER AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
5.13.2 BUYING CRITERIA

6 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ORGANIC CHEMICALS
6.2.1 OLEOCHEMICALS
6.2.1.1 FATTY ALCOHOLS
6.2.1.2 MINERAL STEARATES
6.2.1.3 GLYCERIN
6.2.1.4 OTHER OLEOCHEMICALS
6.2.2 CARBOHYDRATES
6.2.2.1 SUGARS
6.2.2.1.1. ACTUAL SUGARS
6.2.2.1.2. SUGAR ALCOHOLS
6.2.2.1.3. ARTIFICIAL SWEETENERS
6.2.2.2 CELLULOSE
6.2.2.2.1. MICROCRYSTALLINE CELLULOSE
6.2.2.2.2. CELLULOSE ETHERS
6.2.2.2.3. CMC & CROSCARMELLOSE SODIUM
6.2.2.2.4. CELLULOSE ESTERS
6.2.2.3 STARCH
6.2.2.3.1. MODIFIED STARCH
6.2.2.3.2. DRIED STARCH
6.2.2.3.3. CONVERTED STARCH
6.2.3 PETROCHEMICALS
6.2.3.1 GLYCOLS
6.2.3.2 POVIDONES
6.2.3.3 MINERAL HYDROCARBONS
6.2.3.4 ACRYLIC POLYMERS
6.2.3.5 OTHER PETROCHEMICAL EXCIPIENTS
6.2.4 PROTEINS
6.2.5 OTHER ORGANIC CHEMICALS
6.3 INORGANIC CHEMICALS
6.3.1 CALCIUM PHOSPHATE
6.3.2 METAL OXIDES
6.3.3 HALITES
6.3.4 CALCIUM CARBONATE
6.3.5 CALCIUM SULFATE
6.3.6 OTHER INORGANIC CHEMICALS
6.4 OTHER CHEMICALS
Note: Other oleochemicals include natural waxes, specialty esters, phospholipids, ethoxylates, vegetable oils, hard fats, and mono and triglycerides among others.
Note: Other petrochemicals include antioxidants, antimicrobials, dyes, and synthetic compounds such as disodium ethylenediamine tetra-acetate (EDTA), synthetic flavors, silicones, and other vinyl-based polymers. This segment also includes other synthetic materials, such as glycolic acid, hexylene glycol, and triethanolamine among others.
Note: Other organic chemicals segment covers ethyl alcohol, isopropyl alcohol, lactic acid, citric acid, and shellac among others
Note: The other inorganic chemicals segment includes clay, mineral alkalis, mineral acids, mineral buffering salts, and talc among others.
Note: Other Chemicals includes pharmaceutical-grade water and mucilage among others
Note: Tentative segmentation. This can be revised during the course of study.

7 PHARMACEUTICAL EXCIPIENTS, BY FUNCTIONALITY
7.1 INTRODUCTION
7.2 FILLERS & DILUENTS
7.3 SUSPENDING & VISCOSITY AGENTS
7.4 COATING AGENTS
7.5 BINDERS
7.6 FLAVORING AGENTS & SWEETENERS
7.7 DISINTEGRANTS
7.8 COLORANTS
7.9 LUBRICANTS & GLIDANTS
7.10 PRESERVATIVES
7.11 EMULSIFYING AGENTS
7.12 OTHER FUNCTIONALITIES
Note: Other functionalities include chelating agents, solvents, sorbents, plasticizers, humectants, adsorbents, buffers, wetting agents, anti-foaming agents, anti-adherents, emollients, and acidifying & alkalizing agents among others.
Note: Tentative segmentation. This can be revised during the course of study.

8 PHARMACEUTICAL EXCIPIENTS, BY FORMULATION (FORMS)
8.1 INTRODUCTION
8.2 ORAL FORMULATIONS
8.2.1 TABLETS
8.2.2 CAPSULES
8.2.2.1 HARD-GELATIN CAPSULES
8.2.2.2 SOFT-GELATIN CAPSULES
8.2.3 LIQUID FORMULATIONS
8.2.4 OTHER ORAL FORMULATIONS
8.3 TOPICAL FORMULATIONS
8.4 PARENTERAL FORMULATIONS
8.5 OTHER FORMULATIONS
Note: Other oral formulations mainly include sublingual modes of delivery and semi-solid & solid dosage forms among others
Note: Other formulations mainly include advanced drug formulations, such as those administered via inhalation, ocular, transdermal, liquid, semi-solid & solid dosage and amomg others
Note: Tentative segmentation. This can be revised during the course of study.

9 PHARMACEUTICAL EXCIPIENTS, BY FUNCTIONALITY APPLICATION
9.1 INTRODUCTION
9.2 TASTE MASKING
9.3 STABLIZERS
9.4 MODIFIED-RELEASE
9.5 SOLUBILITY & BIOAVAILABLITY ENHANCEMENT
9.6 OTHERS (IF ANY)
Note: Modified Release is inclusive of delayed-release, extended-release, and targeted-release among others
Note: Others segment includes manufacturing aids and among others.
Note: Tentative segmentation. This can be revised during the course of study.

10 PHARMACEUTICAL EXCIPIENTS, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.2.3 RECESSION IMPACT
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.3.7 RECESSION IMPACT
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 REST OF ASIA PACIFIC
10.4.6 RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.2 REST OF LATIN AMERICA
10.5.3 RECESSION IMPACT
10.6 MIDDLE EAST
10.6.1 RECESSION IMPACT
10.7 AFRICA
10.7.1 RECESSION IMPACT

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYERS STRATEGIES/ RIGHT TO WIN
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT
11.6 START-UP/SME EVALUATION MATRIX
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING
11.7 COMPETITIVE SCENARIO AND TRENDS

12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 KEY COMPANIES
12.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC.
12.1.2 ASHLAND INC.
12.1.3 EVONIK INDUSTRIES AG
12.1.4 BASF SE
12.1.5 KERRY GROUP PLC
12.1.6 ROQUETTE FRÈRES
12.1.7 MERCK KGAA
12.1.8 SPI PHARMA (ASSOCIATED BRITISH FOODS PLC)
12.1.9 ADM
12.1.10 WACKER CHEMIE AG
12.1.11 AIR LIQUIDE
12.1.12 DOW
12.1.13 LUBRIZOL CORPORATION ( BERKSHIRE HATHAWAY INC.)
12.1.14 COLORCON
12.1.15 DFE PHARMA
12.2 OTHER PLAYERS
12.2.1 INNOPHOS
12.2.2 JRS PHARMA (J. RETTENMAIER & SÖHNE GMBH + CO KG)
12.2.3 ACTYLIS
12.2.4 MEGGLE GMBH & CO. KG
12.2.5 COREL PHARMA CHEM.
12.2.6 BIOGRUND GMBH
12.2.7 NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
12.2.8 BENEO
12.2.9 FUJI CHEMICAL INDUSTRIES CO., LTD.
12.2.10 R.T. VANDERBILT HOLDING COMPANY, INC.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS